Keywords: amicus, amigal, gets, od, nod, comp, new

Amicus' Amigal gets OD nod from COMP

Article | 24 April 2006

New Jersey, USA-based biopharmaceutical company Amicus Therapeutics, a specialist developer of oral drugs for the treatment of human genetic diseases, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Agalsidase Beta

Fabrazyme

Nystatin

Go to drug listing